996 filings
Page 4 of 50
8-K
73knrdyr7n
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm
ARS
hnv609o
1 May 23
Annual report to shareholders
9:10am
8-K
v4uiqq
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
4
i6w9qc
17 Apr 23
HERON THERAPEUTICS / David Leslie Szekeres ownership change
5:28pm
4
hf6j 2w4q7ysx
17 Apr 23
HERON THERAPEUTICS / JOHN POYHONEN ownership change
5:27pm
4
53kn102nq40b5 g5
17 Apr 23
HERON THERAPEUTICS / Lisa Peraza ownership change
5:27pm
4
nb841ghqd egk80gi
17 Apr 23
HERON THERAPEUTICS / KIMBERLY MANHARD ownership change
5:26pm
SC 13G
4gomokrmt543q
13 Apr 23
HERON THERAPEUTICS / GREAT POINT PARTNERS ownership change
1:58pm
4
w62n74titze9v3ifngf
5 Apr 23
HERON THERAPEUTICS / Craig A Collard ownership change
5:10pm
8-K
2ir u0br6
3 Apr 23
Heron Therapeutics Announces New CEO and Board Chairman
9:10am
8-K
2y74p
23 Mar 23
Results of Operations and Financial Condition
4:10pm
8-K
f2qr0m l9t
13 Mar 23
Other Events
9:11am
8-K
6m0hj6w 2pit423ei8tk
6 Mar 23
Heron Therapeutics Announces U.S. Commercial Launch of APONVIETM for the Management of Postoperative Nausea and Vomiting in Adults
9:11am
3
9lvhdmcdanu9im8zwo
2 Mar 23
HERON THERAPEUTICS / KEVIN KOTLER ownership change
4:13pm
3
8xp048fg
2 Mar 23
HERON THERAPEUTICS / Craig A Collard ownership change
4:11pm
4
qr2dqcc28esj m0rw
24 Feb 23
HERON THERAPEUTICS / Adam Morgan ownership change
7:20pm